Document:

EX-10.4

 Exhibit 10.4 

BLACK DIAMOND THERAPEUTICS, INC. 

2020 EMPLOYEE STOCK PURCHASE PLAN 

The purpose of the Black Diamond Therapeutics, Inc. 2020 Employee Stock Purchase Plan (the “Plan”) is to provide eligible employees
of Black Diamond Therapeutics, Inc. (the “Company”) and each Designated Company (as defined in Section 11) with opportunities to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common
Stock”). 326,364 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2021 and each January 1 thereafter until the Plan terminates pursuant to Section 20, the number of
shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the lesser of (i) 326,364 shares of Common Stock, (ii) 1 percent of the number of shares of Common Stock issued and outstanding on the
immediately preceding December 31, or (iii) such lesser number of shares of Common Stock as determined by the Administrator (as defined in Section 1). 

The Plan includes two components: a Code Section 423 Component (the “423 Component”) and a
non-Code Section 423 Component (the “Non-423 Component”). It is intended for the 423 Component to constitute an “employee stock purchase plan”
within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the “Code”), and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423
Component, which does not qualify as an “employee stock purchase plan” within the meaning of Section 423(b) of the Code, options will be granted pursuant to rules, procedures or sub-plans
adopted by the Administrator designed to comply with applicable laws or achieve tax and other objectives. Except as otherwise provided herein or by the Administrator, the Non-423 Component will operate and be
administered in the same manner as the 423 Component. 

 Unless otherwise defined herein, capitalized terms in this Plan shall have the meaning
ascribed to them in Section 11. 
 1.    Administration. The Plan will be administered by the person or
persons (the “Administrator”) appointed by the Company’s Board of Directors (the “Board”) for such purpose. The Administrator has authority at any time to: (i) adopt, alter and repeal such rules, guidelines and
practices for the administration of the Plan and for its own acts and proceedings as it shall deem advisable; (ii) interpret the terms and provisions of the Plan; (iii) make all determinations it deems advisable for the administration of
the Plan, including to accommodate the specific requirements of applicable laws, regulations and procedures in jurisdictions outside the United States; (iv) decide all disputes arising in connection with the Plan; and (v) otherwise
supervise the administration of the Plan. All interpretations and decisions of the Administrator shall be binding on all persons, including the Company and the Participants. No member of the Board or individual exercising administrative authority
with respect to the Plan shall be liable for any action or determination made in good faith with respect to the Plan or any option granted hereunder. 

2.    Offerings. The Company may make one or more offerings to eligible employees to purchase Common Stock under
the Plan (“Offerings”). The initial Offering will begin and end on dates to be determined by the Administrator. Thereafter, unless otherwise determined by the Administrator, an Offering will begin on the first business day occurring on or
after each January 1 and July 1 and will end on the last business day occurring on or before the following June 30 and December 31, respectively. The Administrator may, in its discretion, designate a different period for any
Offering, provided that no Offering shall exceed 27 months in duration or overlap with any other Offering. 

 3.    Eligibility. Except as otherwise determined by the
Administrator in advance of an Offering, all individuals classified as employees on the payroll records of the Company and each Designated Company are eligible to participate in any one or more of the Offerings under the Plan. The Administrator may
further determine, in advance of an Offering, that most employees are eligible only if, as of the first day of the applicable Offering (the “Offering Date”), they are customarily employed by the Company or a Designated Company for more
than 20 hours a week and have completed at least 30 days of employment. Notwithstanding any other provision herein, individuals who are not contemporaneously classified as employees of the Company or a Designated Company for purposes of the
Company’s or applicable Designated Company’s payroll system are not considered to be eligible employees of the Company or any Designated Company and shall not be eligible to participate in the Plan. In the event any such individuals are
reclassified as employees of the Company or a Designated Company for any purpose, including, without limitation, common law or statutory employees, by any action of any third party, including, without limitation, any government agency, or as a
result of any private lawsuit, action or administrative proceeding, such individuals shall, notwithstanding such reclassification, remain ineligible for participation. Notwithstanding the foregoing, the exclusive means for individuals who are not
contemporaneously classified as employees of the Company or a Designated Company on the Company’s or Designated Company’s payroll system to become eligible to participate in this Plan is through an amendment to this Plan, duly executed by
the Company, which specifically renders such individuals eligible to participate herein. 
 4.    Participation.

 (a)    An eligible employee who is not a Participant in any prior Offering may participate in a subsequent Offering by
submitting an enrollment form to the Company or an 

 
agent designated by the Company (in the manner described in Section 4(b)) at least 15 business days before the Offering Date (or by such other deadline as shall be established by the
Administrator for the Offering). 
 (b)    Enrollment. The enrollment form (which may be in an electronic format
or such other method as determined by the Company in accordance with the Company’s practices) will (a) state a whole percentage to be deducted from an eligible employee’s Compensation per pay period, (b) authorize the purchase of
Common Stock in each Offering in accordance with the terms of the Plan and (c) specify the exact name or names in which shares of Common Stock purchased for such individual are to be issued pursuant to Section 10. An employee who does not
enroll in accordance with these procedures will be deemed to have waived the right to participate. Unless a Participant files a new enrollment form or withdraws from the Plan, such Participant’s deductions and purchases will continue at the
same percentage of Compensation for future Offerings, provided he or she remains eligible. 
 (c)    Notwithstanding the
foregoing, participation in the Plan will neither be permitted nor be denied contrary to the requirements of the Code. 

5.    Employee Contributions. Each eligible employee may authorize payroll deductions at a minimum of
1 percent up to a maximum of 10 percent of such employee’s Compensation for each pay period or such other maximum as may be specified by the Administrator in advance of an Offering. The Company will maintain book accounts showing the
amount of payroll deductions made by each Participant for each Offering. No interest will accrue or be paid on payroll deductions, except as may be required by applicable law. If payroll deductions for purposes of the Plan are prohibited or
otherwise problematic under applicable law (as determined by the Administrator in its discretion), the Administrator may require Participants 

 
to contribute to the Plan by such other means as determined by the Administrator. Any reference to “payroll deductions” in this Section 5 (or in any other section of the Plan) will
similarly cover contributions by other means made pursuant to this Section 5. 
 6.    Deduction Changes.
Except as may be determined by the Administrator in advance of an Offering, a Participant may not increase or decrease his or her payroll deduction during any Offering, but may increase or decrease his or her payroll deduction with respect to the
next Offering (subject to the limitations of Section 5) by filing a new enrollment form at least 15 business days before the next Offering Date (or by such other deadline as shall be established by the Administrator for the Offering). The
Administrator may, in advance of any Offering, establish rules permitting a Participant to increase, decrease or terminate his or her payroll deduction during an Offering. 

7.    Withdrawal. A Participant may withdraw from participation in the Plan by delivering a written notice of
withdrawal to the Company or an agent designated by the Company (in accordance with such procedures as may be established by the Administrator). The Participant’s withdrawal will be effective as of the next business day. Following a
Participant’s withdrawal, the Company will promptly refund such individual’s entire account balance under the Plan to him or her (after payment for any Common Stock purchased before the effective date of withdrawal). Partial withdrawals
are not permitted. Such an employee may not begin participation again during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with Section 4. 

8.    Grant of Options. On each Offering Date, the Company will grant to each eligible employee who is then a
Participant in the Plan an option (“Option”) to purchase on the last day of such Offering (the “Exercise Date”), at the Option Price (as defined herein), the lowest of (a) a 

 
number of shares of Common Stock determined by dividing such Participant’s accumulated payroll deductions on such Exercise Date by the lower of (i) 85 percent of the Fair Market
Value of the Common Stock on the Offering Date, or (ii) 85 percent of the Fair Market Value of the Common Stock on the Exercise Date, (b) 1,470 shares; or (c) such other lesser maximum number of shares as shall have been
established by the Administrator in advance of the Offering; provided, however, that such Option shall be subject to the limitations set forth below. Each Participant’s Option shall be exercisable only to the extent of such Participant’s
accumulated payroll deductions on the Exercise Date. The purchase price for each share purchased under each Option (the “Option Price”) will be 85 percent of the Fair Market Value of the Common Stock on the Offering Date or the
Exercise Date, whichever is less. 
 Notwithstanding the foregoing, no Participant may be granted an Option hereunder if such Participant,
immediately after the Option was granted, would be treated as owning stock possessing 5 percent or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Subsidiary. For purposes of the
preceding sentence, the attribution rules of Section 424(d) of the Code shall apply in determining the stock ownership of a Participant, and all stock which the Participant has a contractual right to purchase shall be treated as stock owned by
the Participant. In addition, no Participant may be granted an Option which permits his or her rights to purchase stock under the Plan, and any other employee stock purchase plan of the Company and its Parents and Subsidiaries, to accrue at a rate
which exceeds $25,000 of the fair market value of such stock (determined on the option grant date or dates) for each calendar year in which the Option is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply
with Section 423(b)(8) of the Code and shall be applied taking Options into account in the order in which they were granted. 

 9.    Exercise of Option and Purchase of Shares. Each employee
who continues to be a Participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Option on such date and shall acquire from the Company such number of whole shares of Common Stock reserved for the purpose of the Plan
as his or her accumulated payroll deductions on such date will purchase at the Option Price, subject to any other limitations contained in the Plan. Unless otherwise determined by the Administrator in advance of an Offering, any amount remaining in
a Participant’s account at the end of an Offering solely by reason of the inability to purchase a fractional share will be carried forward to the next Offering; any other balance remaining in a Participant’s account at the end of an
Offering will be refunded to the Participant promptly. 
 10.    Issuance of Certificates. Certificates or
book-entries at the Company’s transfer agent representing shares of Common Stock purchased under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights
of survivorship, or in the name of a broker authorized by the employee to be his, her or their, nominee for such purpose. 

11.    Definitions. 

The term “Affiliate” means any entity that, directly or indirectly through one or more intermediaries, controls, is controlled by or
is under the common control with the Company. 
 The term “Compensation” means the amount of base pay, prior to salary reduction
such as pursuant to Sections 125, 132(f) or 401(k) of the Code, but excluding overtime, commissions, incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances or travel expenses, income or gains related
to Company stock options or other share-based awards, and similar items. The Administrator shall have the discretion to determine the application of this definition to Participants outside the United States. 

 The term “Designated Company” means any present or future Subsidiary that has been
designated by the Administrator to participate in the Plan. The Administrator may so designate any Subsidiary or Affiliate, or revoke any such designation, at any time and from time to time, either before or after the Plan is approved by the
stockholders, and may further designate such companies or Participants as participating in the 423 Component or the Non-423 Component. The Administrator may also determine which affiliates or eligible
employees may be excluded from participation in the Plan, to the extent consistent with Section 423 of the Code or as implemented under the Non-423 Component, and determine which Designated Company or
Companies will participate in separate Offerings (to the extent that the Company makes separate Offerings). For purposes of the 423 Component, only the Company and its Subsidiaries may be Designated Companies; provided, however, that at any given
time, a Subsidiary that is a Designated Company under the 423 Component will not be a Designated Company under the Non-423 Component. The current list of Designated Companies is attached hereto as Appendix
A. 
 The term “Fair Market Value of the Common Stock” on any given date means the fair market value of the Common Stock
determined in good faith by the Administrator; provided, however, that if the Common Stock is admitted to quotation on The Nasdaq Global Market or another national securities exchange, the determination shall be made by reference to the closing
price on such date. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a closing price. 

 The term “Parent” means a “parent corporation” with respect to the
Company, as defined in Section 424(e) of the Code. 
 The term “Participant” means an individual who is eligible as
determined in Section 3 and who has complied with the provisions of Section 4. 
 The term “Subsidiary” means a
“subsidiary corporation” with respect to the Company, as defined in Section 424(f) of the Code. 

12.    Rights on Termination or Transfer of Employment. If a Participant’s employment terminates for any
reason before the Exercise Date for any Offering, no payroll deduction will be taken from any pay due and owing to the Participant and the balance in the Participant’s account will be paid to such Participant or, in the case of such
Participant’s death, if permitted by the Administrator and valid under applicable law, to his or her designated beneficiary or to the legal representative of his or her estate as if such Participant had withdrawn from the Plan under
Section 7. An employee will be deemed to have terminated employment, for this purpose, if the corporation that employs him or her, having been a Designated Company, ceases to be a Subsidiary or Affiliate, or if the employee is transferred to
any corporation other than the Company or a Designated Company. Unless otherwise determined by the Administrator, a Participant whose employment transfers between, or whose employment terminates with an immediate rehire (with no break in service)
by, Designated Companies or a Designated Company and the Company will not be treated as having terminated employment for purposes of participating in the Plan or an Offering; provided, however, that if a Participant transfers from an Offering under
the 423 Component to an Offering under the Non-423 Component, the exercise of the Participant’s Option will be qualified under the 423 Component only to the extent that such exercise complies with
Section 423 of the Code. If a Participant transfers from an Offering 

 
under the Non-423 Component to an Offering under the 423 Component, the exercise of the Participant’s Option will remain non-qualified under the Non-423 Component. Further, an employee will not be deemed to have terminated employment for purposes of this Section 12, if the employee is on an
approved leave of absence where the employee’s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise provides in writing.

 13.    Special Rules and Sub-Plans. Notwithstanding anything herein to
the contrary, the Administrator may adopt special rules or sub-plans applicable to the employees of a particular Designated Company, whenever the Administrator determines that such rules are necessary or
appropriate for the implementation of the Plan in a jurisdiction where such Designated Company has employees, regarding, without limitation, eligibility to participate in the Plan, handling and making of payroll deductions or contributions by other
means, establishment of bank or trust accounts to hold payroll deductions, payment of interest, conversion of local currency, obligation to pay payroll tax, withholding procedures and handling of share issuances, any of which may vary according to
applicable requirements; provided that if such special rules or sub-plans are inconsistent with the requirements of Section 423(b) of the Code the employees subject to such special rules or sub-plans will participate in the Non-423 Component. 

14.    Optionees Not Stockholders. Neither the granting of an Option to a Participant nor the deductions from his
or her pay shall result in such Participant becoming a holder of the shares of Common Stock covered by an Option under the Plan until such shares have been purchased by and issued to him or her. 

 15.    Rights Not Transferable. Rights under the Plan are not
transferable by a Participant other than by will or the laws of descent and distribution, and are exercisable during the Participant’s lifetime only by the Participant. 

16.    Application of Funds. All funds received or held by the Company under the Plan may be combined with other
corporate funds and may be used for any corporate purpose, unless otherwise required under applicable law. 

17.    Adjustment in Case of Changes Affecting Common Stock. In the event of a subdivision of outstanding shares of
Common Stock, the payment of a dividend in Common Stock or any other change affecting the Common Stock, the number of shares approved for the Plan and the share limitation set forth in Section 8 shall be equitably or proportionately adjusted to
give proper effect to such event. 
 18.    Amendment of the Plan. The Board may at any time and from time to
time amend the Plan in any respect, except that without the approval within 12 months of such Board action by the stockholders, no amendment shall be made increasing the number of shares approved for the 423 Component of the Plan or making any other
change that would require stockholder approval in order for the Plan, as amended, to qualify as an “employee stock purchase plan” under Section 423(b) of the Code. 

19.    Insufficient Shares. If the total number of shares of Common Stock that would otherwise be purchased on any
Exercise Date plus the number of shares purchased under previous Offerings under the Plan exceeds the maximum number of shares issuable under the Plan, the shares then available shall be apportioned among Participants in proportion to the amount of
payroll deductions accumulated on behalf of each Participant that would otherwise be used to purchase Common Stock on such Exercise Date. 

 20.    Termination of the Plan. The Plan may be terminated at any
time by the Board. Upon termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded. Unless terminated earlier, the Plan shall automatically terminate on the ten year anniversary of the Effective Date. 

21.    Compliance with Law. The Company’s obligation to sell and deliver Common Stock under the Plan is
subject to applicable laws and the completion of any registration or qualification of the Common Stock under any U.S. or non-U.S. local, state or federal securities or exchange control law, or under rulings or
regulations of the SEC or of any other governmental regulatory body, and to obtaining any approval or other clearance from any U.S. and non-U.S. local, state or federal governmental agency, which registration,
qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable. The Company is under no obligation to register or qualify the Common Stock with the SEC or any other U.S. or
non-U.S. securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of such stock. 

22.    Governing Law. This Plan and all Options and actions taken thereunder shall be governed by, and construed in
accordance with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of Commonwealth of
Massachusetts applied without regard to conflict of law principles. 
 23.    Issuance of Shares. Shares may be
issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source. 

 24.    Tax Withholding. Participation in the Plan is subject to
any applicable U.S. and non-U.S. federal, state or local tax withholding requirements on income the Participant realizes in connection with the Plan. Each Participant agrees, by entering the Plan, that the
Company or any Subsidiary or Affiliate may withhold from a Participant’s wages, salary or other compensation at any time the amount necessary for the Company or any Subsidiary or Affiliate to meet applicable withholding obligations, including
any withholding required to make available to the Company or any Subsidiary or Affiliate any tax deductions or benefits attributable to the sale or disposition of Common Stock by such Participant. In addition, the Company or any Subsidiary or
Affiliate may withhold from the proceeds of the sale of Common Stock or use any other method of withholding that the Company or any Subsidiary or Affiliate deems appropriate to the extent permitted by U.S. Treasury Regulation Section 1.423-2(f) with respect to the 423 Component. The Company will not be required to issue any Common Stock under the Plan until such obligations are satisfied. 

25.    Notification Upon Sale of Shares under the 423 Component. Each Participant agrees, by entering the 423
Component of the Plan, to give the Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased or
within one year after the date such shares were purchased. 
 26.    Effective Date and Approval of Shareholders.
The Plan shall take effect on the date immediately preceding the later of the date it is adopted by the Board and the date it is approved by the holders of a majority of the votes cast at a meeting of stockholders at which a quorum is present or by
written consent of the stockholders. 
 DATE APPROVED BY BOARD OF DIRECTORS: December 5, 2019 

DATE APPROVED BY STOCKHOLDERS: January 14, 2020 

 APPENDIX A 

Designated Companies 
 Black
Diamond Therapeutics (Canada) Inc.Exhibit

Exhibit 10.1

SEPARATION AND RELEASE AGREEMENT

PERSONAL & CONFIDENTIAL                        
January 15, 2020
Christine T. Komola
via email

RE: Separation Agreement and Release
Dear Christine:
This letter of agreement and general release (“Agreement”) confirms our mutual agreement regarding the terms and conditions of your separation from employment with Covetrus, Inc. and each of its subsidiaries and affiliates (the “Company”).  You agree with the Company as follows:
		
	1.
	Last Day of Employment.  Your last day of employment with the Company will be January 15, 2020 (“Last Day of Employment”).  Your employment and your participation in the Company’s employee benefit plans and programs shall terminate on your Last Day of Employment.  

		
	2.
	Unused Vacation Pay.  As you are aware, the Company migrated to a Flexible Time Off Policy effective January 1, 2020.  Therefore, you did not accrue paid time off from January 1, 2020 through January 15, 2020.  All accrued and unused vacation as of December 31, 2019, up to the max carryover of 40 hours, will be paid to you on your last day of employment at the base rate of pay in effect on December 31, 2019, subject to applicable withholding.

		
	3.
	Separation Benefits.  If you (i) execute this Agreement by February 5, 2020 and do not timely revoke it, (ii) return all Company property, and (iii) otherwise comply with your obligations under this Agreement and your continuing obligations under your Employment Agreement dated February 7, 2019  (the “Employment Agreement”), your Invention and Non-Disclosure Agreement dated February 7, 2019, and your Non-Competition and Non-Solicitation Agreement dated February 7, 2019, the Company will provide you with the following consideration:

		
	a)
	Severance equal to eighteen (18) months of your base salary as of the Last Day of Employment (the “Severance Period”), less all applicable taxes and withholdings, paid in regular payroll installments over the Severance Period;

		
	b)
	A non-prorated annual bonus for fiscal year 2019, achieved based on Company performance for fiscal year 2019 and currently anticipated to be $268,125, less all applicable taxes and withholding, payable at the same time at which annual bonuses are paid to other executives, but no later than March 15, 2020.

		
	c)
	The following payments shall be made to you in the next available payroll cycle following your return and non-revocation of a fully executed Agreement.  Such payments shall be subject to all applicable taxes and withholding: 

		
	i)
	An annual bonus for fiscal year 2020 of $20,034, equal to 100% of your 2020 target bonus amount of $487,500, pro-rated through your Last Day of Employment;

		
	ii)
	An aggregate payment of $20,000 as reimbursement for financial planning, tax planning and legal costs/fees for tax years 2019 and 2020, grossed up so as to be tax neutral to you;

		
	iii)
	A payment of $30,000 for outplacement services to be used in your discretion, grossed up so as to be tax neutral to you;

		
	iv)
	A payment of $26,100, grossed up so as to be tax neutral to you, with respect to the early termination of your lease in Portland, Maine, entered into in connection with your employment and at the request of the Company; 

		
	v)
	A payment of $10,000, grossed up so as to be tax neutral to you, as reimbursement for the cost of packing and shipping personal belongings to your home State; and

		
	vi)
	Provided you timely elect and remain eligible for health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), a payment of $19,308, grossed up so as to be tax neutral to you, representing the employer portion of continued health insurance coverage at your current election levels through the Severance Period.

1

		
	d)
	You shall be permitted to utilize the remainder of the executive coaching services in 2020 previously contracted by the Company for your benefit.

		
	e)
	Notwithstanding anything to the contrary set forth in the equity awards granting you time based stock options and restricted stock units (the “Equity Awards”), the portion of your Equity Awards that would, but for your separation from the Company, vest over the two-month period commencing on your Last Day of Employment, shall vest in full on your Last Day of Employment.

		
	4.
	Release.  

		
	a)
	In consideration of the separation benefits set forth in Paragraph 3 hereof, to the fullest extent permitted by law you waive, release and forever discharge the Company and each of its past and current parents, subsidiaries, affiliates, and each of its and their respective past and current directors, officers, members, trustees, employees, representatives, agents, attorneys, employee benefit plans and such plans’ administrators, fiduciaries, trustees, recordkeepers and service providers, and each of its and their respective successors and assigns, each and all of them in their personal and representative capacities (collectively the “Company Releasees”) from any and all claims legally capable of being waived, grievances, injuries, controversies, agreements, covenants, promises, debts, accounts, actions, causes of action, suits, arbitrations, sums of money, attorneys’ fees, costs, damages, or any right to any monetary recovery or any other personal relief, whether known or unknown, in law or in equity, by contract, tort (including claims for fraud, defamation, emotional distress, and discharge in violation of public policy), law of trust or pursuant to federal, state or local statute, regulation, ordinance or common law, which you now have, ever have had, or may hereafter have, based upon or arising from any fact or set of facts, whether known or unknown to you, from the beginning of time until the date of execution of this Agreement, arising out of or relating in any way to your employment relationship with the Company or the Company Releasees or other associations with the Company or the Company Releasees or any termination thereof, including all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy.  

		
	b)
	Without limiting the generality of the foregoing, this waiver, release, and discharge includes any claim or right, to the extent legally capable of being waived, based upon or arising under any federal, state or local fair employment practices or equal opportunity laws, including, but not limited to, the Rehabilitation Act of 1973, the Worker Adjustment and Retraining Notification Act, 42 U.S.C. Section 1981, Title VII of the Civil Rights Act of 1964, the Equal Pay Act, the Employee Retirement Income Security Act (“ERISA”) (including, but not limited to, claims for breach of fiduciary duty under ERISA), the Americans With Disabilities Act, the Family and Medical Leave Act of 1993, the Maine Human Rights Act, the Maine Equal Pay Law, the Maine Civil Rights Act, the Maine Whistleblower Protection Act, the Maine Family Medical Leave Requirements Act, the Maine Minimum Wage Law, the Maine Wage and Hour Law, the Maine Wage Payment Law, the Maine Severance Pay Law, the retaliation provisions of the Maine Workers’ Compensation Law, the Maine Family Sick Leave Act, the Maine Conditions of Employment Law, the Maine Employee Social Media Privacy Act, the Maine Substance Abuse Testing Law, the Maine State Constitution, the Massachusetts Fair Employment Practices Law,  M.G.L. ch. 151B; the Massachusetts Civil Rights Act, M.G.L. ch. 12 § 11H, et seq.; the Massachusetts Equal Rights Act, M.G.L. ch. 93 § 102, et seq.; the Massachusetts Privacy Statute, M.G.L. ch. 214 § 1B; the Massachusetts Sexual Harassment Statute, M.G.L. ch. 214 § 1C; the Massachusetts Equal Pay Act, M.G.L. ch. 149 § 105A; the Massachusetts Wage Act, M.G.L. ch. 149 §§ 148, 150, et seq.; the Massachusetts Minimum Fair Wage Law, M.G.L. ch. 151; the Massachusetts Family and Medical Leave Law, M.G.L. ch. 175M; any claims that may be released under Massachusetts labor statutes, M.G.L. ch. 149; - including specifically (but without limitation) all claims under the Wage Act for (a) non-payment of wages (Mass. G.L. c 149, § 148), (b) retaliation (Mass. G.L. c. 149, § 148A), and (c) misclassification (Mass. G.L. c. 149, § 148B); any and all claims under any other federal or state statute or regulation, or any local ordinance, law or regulation, or any claim that was or could have been asserted under common law, any and all claims under any other federal or state statute or regulation, or any local ordinance, law or regulation, or any claim that was or could have been asserted under common law; and all amendments thereto. 

Age Claim Waiver.  In addition to all other claims released under this Agreement, you understand and agree that you are waiving all claims available against the Company Releasees arising out of your employment with the Company or the termination of your employment under the Age Discrimination in Employment Act (“ADEA”) (29 U.S.C. Section 621, et seq.).
Wage Acknowledgment.  You acknowledge and represent that, other than the consideration set forth in this Agreement, the Company has paid or provided for the payment of, all salary, wages, bonuses, accrued vacation/paid time off, severance, reimbursable expenses, commissions, and any and all other benefits and compensation due to you.

2

		
	c)
	You represent that you have not filed any lawsuits or administrative complaints or made any other charges, either in your name or on behalf of any other person or entity, against the Company in any local, state or federal court or with any local, state or federal administrative agency. You further represent that you have not sustained any work-related injuries. You also agree to waive any right to bring, maintain, or participate in a class action, collective action, or representative action against the Company and/or the Company Releasees to the fullest extent permitted by law.  You agree that you may not serve as a representative of a class action, collective action, or representative action, may not participate as a member of a class action, collective action, or representative action, and may not recover any relief from a class action, collective action, or representative action.  You further agree that if you are included within a class action, collective action, or representative action, you will take all steps necessary to opt-out of the action or refrain from opting in, as the case may be.  You are not waiving any right to challenge the validity of this Paragraph 3(b) on any grounds that may exist in law and equity.  However, the Company and the Company Releasees reserve the right to attempt to enforce this Agreement, including this Paragraph 4(b), in any appropriate forum.

		
	d)
	Notwithstanding the generality of the foregoing, nothing herein constitutes a release or waiver by you of, or prevents you from making or asserting: (i) any claim or right you may have under COBRA; (ii) any claim or right you may have for unemployment insurance or workers’ compensation benefits (other than for retaliation under workers’ compensation laws); (iii) any claim to vested benefits under the written terms of a qualified employee pension benefit plan; (iv) any medical claim incurred during your employment that is payable under applicable medical plans or an employer-insured liability plan; (v) any claim or right that may arise after the execution of this Agreement; (vi) any claim or right you may have under this Agreement; (vii) any claim or right you may have to indemnification as set forth in Section 9 below; or (viii) any claim that is not otherwise waivable under applicable law.

		
	e)
	In addition, nothing herein shall prevent you from filing a charge or complaint with the Equal Employment Opportunity Commission (“EEOC”) or similar federal or state fair employment practices agency or interfere with your ability to participate in any investigation or proceeding conducted by such agency; provided, however, that pursuant to Paragraph 3(a), you are waiving any right to recover monetary damages or any other form of personal relief from the Company Releasees to the extent any such charge, complaint, investigation or proceeding asserts a claim subject to the release in Paragraph 3(a) above. To the extent you receive any such personal or monetary relief in connection with any such charge, complaint, investigation or proceeding, the Company will be entitled to an offset for the payment made pursuant to Paragraph 3 of this Agreement.  

		
	5.
	Return of Property.  You agree that on or before your Last Day of Employment, you will return to the Company all of its property, including, but not limited to, computers, cell phones, files, and documents, including any correspondence or other materials containing trade secrets of the Company, identification cards, credit cards, keys, equipment, software and data, however stored.  To the extent you have any Company information or material stored on any PDA, personal computer, personal email, hard drive, thumb drive, cloud or other electronic storage device, you agree to cooperate with the Company in permanently deleting such information from such devices, subject to any Company litigation preservation directive then in effect.

		
	6.
	Protection of Confidential Information.  Except as expressly permitted in Paragraph 8 of this Agreement or if otherwise required by law, you agree that you will not at any time, directly or indirectly, disclose any trade secret, confidential or proprietary information you have learned by reason of your association with the Company or use any such information to the detriment of the Company, its parents, affiliates or subsidiaries, or to the benefit of any business or enterprise that competes with the Company, its parents, affiliates or subsidiaries.  You represent and agree that you have complied with, and you will continue to comply with, the terms of your Inventions and Non-Disclosure Agreement.

		
	7.
	Mutual Non-Disparagement.   Except as expressly permitted in Paragraph 8 of this Agreement, you agree that you shall not at any time make any written or oral comments or statements of a defamatory or disparaging nature regarding the Company and/or the Company Releasees and you shall not take any action that would cause the Company and/or the Company Releasees any embarrassment or humiliation or otherwise cause or contribute to their being held in disrepute.  The Company agrees to direct all officers and directors not to make at any time any written or oral comments or statements of a defamatory or disparaging nature regarding you.  

		
	8.
	Reports to Government Entities.  Nothing in this Agreement restricts or prohibits you from initiating communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including without limitation, the EEOC, the Department of Labor, the National Labor Relations Board, the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority, the Occupational Safety and Health Administration,  the U.S. Congress, any other federal, state, or local government agency or commission, and any agency Inspector General (collectively, the 

3

“Regulators”), or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation. You do not need the prior authorization of the Company to engage in conduct protected by this Paragraph, and you do not need to notify the Company that you have engaged in such conduct.  This Agreement does not limit your right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of the law. However, to the maximum extent permitted by law, you are waiving your right to receive any individual monetary relief from the Company or any other Company Releasee (as defined above in Paragraph 3) resulting from the released claims, regardless of whether you or another party has filed them, and in the event you obtain such monetary relief the Company will be entitled to an offset for the payment made pursuant to this Agreement.  You recognize and agree that, in connection with any such activity outlined above, you must inform the Regulators, your attorney, a court or a government official that the information you are providing is confidential. Despite the foregoing, you are not permitted to reveal to any third-party, including any governmental, law enforcement, or regulatory authority, information you came to learn during the course of your employment with the Company that is protected from disclosure by any applicable privilege, including but not limited to the attorney-client privilege and/or attorney work product doctrine. The Company does not waive any applicable privileges or the right to continue to protect its privileged attorney-client information, attorney work product, and other privileged information.
Please take notice that federal law provides criminal and civil immunity to federal and state claims for trade secret misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law.
		
	9.
	Indemnification.  Nothing in this Agreement or elsewhere shall reduce or otherwise adversely affect any rights that you have to contribution, indemnification, or advancement of expenses (including, without limitation advancement of attorney’s fees) whether under the Employment Agreement, that certain Indemnification Agreement between you and the Company dated February 7, 2019, or otherwise.  Following the Last Day of Employment, such rights to indemnification shall remain in full force and effect in accordance with their terms and shall not be reduced or adversely affected by anything contained herein.

		
	10.
	Non-Admission.  It is understood and agreed that neither the execution of this Agreement nor the terms of this Agreement constitute an admission of liability to you by the Company or the Company Releasees, and such liability is expressly denied.  It is further understood and agreed that no person shall use the Agreement, or the consideration paid pursuant thereto, as evidence of an admission of liability, inasmuch as such liability is expressly denied.

		
	11.
	Acknowledgments.  You hereby acknowledge that: 

		
	a)
	The Company advises you to consult with an attorney before signing this Agreement; 

		
	b)
	You have obtained independent legal advice from an attorney of your own choice with respect to this Agreement, or you have knowingly and voluntarily chosen not to do so;  

		
	c)
	You freely, voluntarily and knowingly entered into this Agreement after due consideration; 

		
	d)
	You have had a minimum of twenty-one (21) days to review and consider this Agreement and the General Release;

		
	e)
	You and the Company agree that changes to the Company’s offer contained in this Agreement, whether material or immaterial, will not restart the twenty-one (21) day consideration period provided for in Paragraph 11(d) above;

		
	f)
	You have a right to revoke this Agreement by notifying the undersigned representative in writing, via hand delivery, facsimile or electronic mail, within seven (7) days of your execution of this Agreement;

		
	g)
	In exchange for your waivers, releases and commitments set forth herein, including your waiver and release of all claims arising under the ADEA, the payments, benefits and other considerations that you are receiving pursuant to this Agreement exceed any payment, benefit or other thing of value to which you would otherwise be entitled, and are just and sufficient consideration for the waivers, releases and commitments set forth herein; and

		
	h)
	No promise or inducement has been offered to you, except as expressly set forth herein, and you are not relying upon any such promise or inducement in entering into this Agreement.  

		
	12.
	Medicare Disclaimer.  You acknowledge that you are not a Medicare beneficiary as of the time you enter into this Agreement.  To the extent that you are a Medicare beneficiary, you agree to contact a Company Human Resources Representative for further instruction.

4

		
	13.
	Miscellaneous.

		
	a)
	Entire Agreement.  This Agreement sets forth the entire agreement between you and the Company and replaces any other oral or written agreement between you and the Company relating to the subject matter of this Agreement, including, without limitation, any prior offer letters and/or employment agreements, except to the extent you have continuing obligations to the Company under your Employment Agreement, your Invention and Non-Disclosure Agreement, and your Non-Competition and Non-Solicitation Agreement.    

		
	b)
	Governing Law.  This Agreement shall be construed, performed, enforced and in all respects governed in accordance with the laws of the State of Delaware, without giving effect to the principles of conflicts of law thereof.  Additionally, all disputes arising from or related to this Agreement shall be brought in a state or federal court in Maine, and the parties hereby expressly consent to the jurisdiction of such courts for all purposes related to resolving such disputes.

		
	c)
	Severability.  Should any provision of this Agreement be held to be void or unenforceable, the remaining provisions shall remain in full force and effect, to be read and construed as if the void or unenforceable provisions were originally deleted. 

		
	d)
	Amendments.  This Agreement may not be modified or amended, except upon the express written consent of both you and the Company.  

		
	e)
	Waiver.  A waiver by either party hereto of a breach of any term or provision of the Agreement shall not be construed as a waiver of any subsequent breach.

		
	f)
	Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement.

		
	g)
	Effective Date.  This Agreement will become effective and enforceable upon the expiration of the seven (7) day revocation period provided for in Paragraph 11(f) above (the “Effective Date”).  If you fail to return an executed original by February 5, 2020 (or otherwise revoke this Agreement pursuant to Paragraph 11(f) above), this Agreement, including but not limited to the obligation of the Company to provide the separation benefits provided in Paragraph 3 above, shall be deemed automatically null and void.

If the above accurately states our agreement, including the separation, waiver and release, kindly sign below and return the original Agreement to me no later than February 5, 2020. 
                     Sincerely,
Covetrus, Inc. 

                    
By: /s/ Dustin K. Finer        
Name: Dustin K. Finer
Title: Chief Administrative Officer
Date: January 15, 2020        

                    

UNDERSTOOD, AGREED TO AND ACCEPTED WITH THE
INTENTION TO BE LEGALLY BOUND:

By: /s/ Christine T. Komola        
Name: Christine T. Komola
Date: January 15, 2020
            

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]